Effect of light supply on CO2 capture from atmosphere by Chlorella vulgaris and Pseudokirchneriella subcapitata

Carbon dioxide (CO₂) is one of the primary greenhouse gases that contribute to climate change. Consequently, emission reduction technologies will be needed to reduce CO₂ atmospheric concentration. Microalgae may have an important role in this context. They are photosynthetic microorganisms that are able to fix atmospheric CO₂ using solar energy with efficiency ten times higher than terrestrial plants. The objectives of this study were: (i) to analyse the effect of light supply on the growth of Chlorella vulgaris and Pseudokirchneriella subcapitata; (ii) to assess the atmospheric CO₂ capture by these microalgae; and (iii) to determine the parameters of the Monod model that describe the influence of irradiance on the growth of the selected microalgae. Both microalgae presented higher growth rates with high irradiance values and discontinuous light supply. The continuous supply of light at the highest irradiance value was not beneficial for C. vulgaris due to photooxidation. Additionally, C. vulgaris achieved the highest CO₂ fixation rate with the value of 0.305 g-CO₂ L^?1 d^?1. The parameters of the Monod model demonstrated that C. vulgaris can achieve higher specific growth rates (and higher CO₂ fixation rates) if cultivated under higher irradiances than the studied values. The presented results showed that microalgal culture is a promising strategy for CO₂ capture from atmosphere.     

Is there a role for fetal interventions in gastroschisis management? – An updated comprehensive review

We conducted a comprehensive evidence-based review on the epidemiology and current standard of care of gastroschisis management as well as the pathophysiology, rationale and feasibility of fetal therapy as a viable alternative. Gastroschisis is a periumbilical abdominal wall defect characterized by abdominal viscera herniation in utero. It affects 4 in 10 000 live births, but the prevalence has steadily increased in recent years. Gastroschisis is typically diagnosed on routine second-trimester ultrasound. The overall prognosis is favorable, but complex gastroschisis, which accounts for about 10% to 15% of cases, is associated with a higher mortality, significant disease burden and higher healthcare costs due to long- and short-term complications. The current standard of care has yet to be established but generally involves continued fetal surveillance and multidisciplinary perinatal care. Postnatal surgical repair is achieved with primary closure, staged silo closure or sutureless repair. Experimental animal studies have demonstrated the feasibility of in utero closure, antiinflammatory therapy and prenatal regenerative therapy. However, reports of early preterm delivery and amnioinfusion trials have failed to show any benefit in humans. Further experimental studies and human trials are necessary to demonstrate the potential benefit of fetal therapy in gastroschisis.